Abiopharma

Zai Lab Announces Strategic Partnership with MediLink Therapeutics to Develop a Novel LRRC15 Antibody-Drug Conjugate

Celularity Completes Major Balance Sheet Restructuring, Retires All $41.6 Million in Senior Secured Debt

Celularity Completes Major Balance Sheet Restructuring, Retires All $41.6 Million in Senior Secured Debt

Share Buy Back – Daily Share Buy-Back Notice (Market Acquisition)

Share Buy Back - Daily Share Buy-Back Notice: Share Buy Back - Daily Share Buy-Back Notice

New Form 6-K - Valneva SE Filed: 2025-08-18 AccNo: 0001836564-25-000009 Size: 42 KB

Lawsuit DEADLINE: Investors who purchased over $100,000 worth of shares of Alto Neuroscience, Inc. (NYSE: ANRO) between Feb. and Oct. 2024 should contact the Shareholders Foundation

Genprex Receives Notice of Allowance for Multiple Patents for Reqorsa® Gene Therapy with PD-L1 and PD-1 Antibodies to Treat Cancers

New Form 424B3 - Biodexa Pharmaceuticals Plc Filed: 2025-08-18 AccNo: 0001214659-25-012379 Size: 35 KB

New Form 8-K - Genprex, Inc. Filed: 2025-08-18 AccNo: 0001437749-25-027191 Size: 169 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 424B3 - Biodexa Pharmaceuticals Plc Filed: 2025-08-18 AccNo: 0001214659-25-012378 Size: 35 KB

Co-Diagnostics, Inc. to Host Booth at 17th Next Generation Dx Summit in Washington, D.C.

New Form 424B3 - Biodexa Pharmaceuticals Plc Filed: 2025-08-18 AccNo: 0001214659-25-012377 Size: 35 KB

First Patient Enrolled in Merit Medical’s WRAPSODY (WRAP) North America Registry

New Form SC 14D9 - Y-mAbs Therapeutics, Inc. Filed: 2025-08-18 AccNo: 0001104659-25-079582 Size: 1 MB